Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2002
12/12/2002WO2002098913A2 Polypeptides and corresponding polynucleotides for prophylaxis and treatment of colon cancer
12/12/2002WO2002098912A2 Guanylate-cyclase c ligand, administered via the airways, for the treatment of respiratory airway problems
12/12/2002WO2002098911A2 Insecticidal proteins and synergistic combinations thereof
12/12/2002WO2002098910A1 Production of a stress protein
12/12/2002WO2002098909A1 Vaccines
12/12/2002WO2002098908A2 Osteoclastogenesis inhibitory factor, sequence coding for it and uses
12/12/2002WO2002098907A2 Cation conducting gabaa receptors and their use
12/12/2002WO2002098900A2 Novel human proteins, polynucleotides encoding them and methods of using the same
12/12/2002WO2002098899A2 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098885A1 Modified psma ligands and uses related thereto
12/12/2002WO2002098531A1 Methods for purifying highly anionic proteins
12/12/2002WO2002098458A1 Sphingosine kinase interacts with traf2 and modulates tumor necrosis factor-induced cellular activity
12/12/2002WO2002098457A2 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses
12/12/2002WO2002098456A2 Antigens and vectors for vaccination
12/12/2002WO2002098454A2 Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools
12/12/2002WO2002098452A1 Mixtures of growth hormone drug-oligomer conjugates compromising polyalkylene glycol, uses thereof, and methods of making same
12/12/2002WO2002098451A1 Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
12/12/2002WO2002098448A1 Methods and compositions for modulating ace-2 activity
12/12/2002WO2002098443A2 Stabilised mrna with an increased g/c content and optimised codon for use in gene therapy
12/12/2002WO2002098441A2 Method of treating metabolic disorders using neuronatin polypeptides
12/12/2002WO2002098437A1 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof
12/12/2002WO2002098401A1 Medicinal composition containing mucin
12/12/2002WO2002098369A2 Mutant forms of cholera holotoxin as an adjuvant
12/12/2002WO2002098368A2 Mutant forms of cholera holotoxin as an adjuvant
12/12/2002WO2002098365A2 Conditioned cell culture media and uses thereof
12/12/2002WO2002098362A2 Use of rank antagonists to treat cancer
12/12/2002WO2002098360A2 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
12/12/2002WO2002098359A2 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
12/12/2002WO2002098358A2 Methods of diagnosis and treatment of androgen-dependent prostate cancer, prostate cancer undergoing androgen-withdrawal, and androgen-independent prostate cancer
12/12/2002WO2002098356A2 Ppp2cs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002098348A2 Glp-1 formulations with protracted time action
12/12/2002WO2002098232A1 Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
12/12/2002WO2002098216A1 Animal model for allergy
12/12/2002WO2002088302A9 Method for secreting proteins by bacteria, leader sequences and vectors for carrying out said method
12/12/2002WO2002086072A8 Antimicrobial polypeptides and their uses
12/12/2002WO2002086058A9 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence
12/12/2002WO2002085939A8 Novel molecules of the card-related protein family and uses thereof
12/12/2002WO2002085306A3 Use of follistatin to increase muscle mass
12/12/2002WO2002083164A3 Method and composition for prophylaxis of diabetes
12/12/2002WO2002083081A3 Prostate cancer-related compositions, methods and kits based on dna macroarray protemics platforms
12/12/2002WO2002079246A3 Human arginine-rich protein-related compositions
12/12/2002WO2002079239A9 Chimeric filovirus glycoprotein
12/12/2002WO2002079232A3 Reducing the immunogenicity of fusion proteins
12/12/2002WO2002077249A3 Type iii bacterial strains for use in medicine
12/12/2002WO2002074923A9 Targets and screens for agents useful in controlling parasitic nematodes
12/12/2002WO2002074798A3 The genome of a bifidobacterium
12/12/2002WO2002074327A3 Compositions and methods for treating gonadotrophin related illnesses
12/12/2002WO2002072015A3 M cell directed vaccines
12/12/2002WO2002070552A3 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF
12/12/2002WO2002064161A3 Method and compositions for immunization with the pseudomonas v antigen
12/12/2002WO2002062843A3 Modified erythropoietin (epo) with reduced immunogenicity
12/12/2002WO2002062297A9 Methods and compositions for modulating gluconeogenesis using pgc-1
12/12/2002WO2002061113A3 Nucleic acid derived vaccine that encodes an antigen linked to a polypeptide that promotes antigen presentation
12/12/2002WO2002059612A3 Animal model and cell-line expressing modified chlorine channel
12/12/2002WO2002058534A3 Compositions and methods for the therapy and diagnosis of colon cancer
12/12/2002WO2002053723A3 Degradation and detection of tse infectivity
12/12/2002WO2002050106A3 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4
12/12/2002WO2002046404A3 Schizophrenia-related voltage-gated ion channel gene and protein
12/12/2002WO2002044718A3 S.aureus protein staau r2, gene encoding it and uses thereof
12/12/2002WO2002044354A3 Molecules of the card-related protein family and uses thereof
12/12/2002WO2002038599A3 A plant development regulating gene and its uses
12/12/2002WO2002036774A3 Derivatives of the human macrophage-migration inhibition factor (mif) and use thereof in pharmaceutical preparations in screening methods or the identification of analogues, agonists and antagonists
12/12/2002WO2002034891A3 Immortalized preosteoblasts and method for their production
12/12/2002WO2002033090A3 Pharmaceutical preparations and methods for inhibiting tumors
12/12/2002WO2002032942A3 Compositions and methods for modulating rsv infection and immunity
12/12/2002WO2002032463A9 Methods of treating cancers by stimulating dendritic cells or lymphomas with certain tnf molecules
12/12/2002WO2002030983A3 Plasma fraction containing bikunin, method for the production thereof and use of the same
12/12/2002WO2002030958A3 Casein peptide fragments with growth-influencing activity on cell cultures
12/12/2002WO2002028893A3 Plant cyclin-dependent kinase inhibitors
12/12/2002WO2002026784A3 Matrix proteins m1 and m2 of infections salmon anaemia virus
12/12/2002WO2002024749A3 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
12/12/2002WO2002018557A3 Human kinases
12/12/2002WO2002018439A3 52991, a human transporter protein and uses therefor
12/12/2002WO2002018434A3 Proteins related to schizophrenia and uses thereof
12/12/2002WO2002008292A3 Human monoclonal antibody against hepatitis c virus e2 glycoprotein
12/12/2002WO2002000874A1 Polypeptides, use thereof and process for producing the same
12/12/2002WO2001093983A9 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/12/2002WO2001092298A3 MUTEINS OF A CHAIN OF A PROTEIN FROM THE SUPERFAMILY OF GROWTH FACTOR TGF-$g(b)
12/12/2002WO2001090309A9 Peptides that stimulate mycobacterial growth
12/12/2002WO2001089568A9 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
12/12/2002WO2001085786A9 Human histamine h4 receptor
12/12/2002WO2001084921A9 Transgenic animal
12/12/2002WO2001083695A9 Dna sequences encoding dystrophin minigenes and methods of use thereof
12/12/2002WO2001047942A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
12/12/2002WO2001038360A9 Novel hcv non-structural polypeptide
12/12/2002WO2001027303A9 Adeno-associated virus vectors encoding factor viii and methods of using the same
12/12/2002WO2001018207A9 Human 7tm proteins receptors and polynucleotides encoding the same
12/12/2002WO2001012816A9 Porcine endovirus gag and env and diagnostic uses thereof
12/12/2002WO2000032152A3 Compositions and methods for regulating bacterial pathogenesis
12/12/2002US20020188961 Non human transgenic animal in which the expression of the gene coding for insulin is deleted
12/12/2002US20020188115 Reagents and methods useful for detecting diseases of the breast
12/12/2002US20020188114 Nucleotide sequences coding polypeptide for use in the treatment, prevention, diagnosis, and classification of tumors
12/12/2002US20020188110 Transforming growth factor alpha HI
12/12/2002US20020188109 Expression vector for use transformation of yeast cells
12/12/2002US20020188108 Detection of ribosome binding protein; obtain ribosome, incubate with binding protein, detect formation of ribosome complex
12/12/2002US20020188106 Tau protein epitopes for use in the treatment of alzheimer's disease
12/12/2002US20020188104 Protein for use in the treatment of autoimmune, viral and cancer diseases
12/12/2002US20020188103 Chimeric dna-binding/dna methyltransferase nucleic acid and polypeptide and uses thereof
12/12/2002US20020188102 Peptide for use as microbiocides
12/12/2002US20020188101 Conjugated peptide nucleic acids having enhanced cellular uptake
1 ... 1702 1703 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 ... 2916